phenytoin has been researched along with dinoprostone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (50.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Duffy, EM; Jorgensen, WL | 1 |
| Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Andurén, I; Lerner, UH; Modéer, T | 1 |
| Brunius, G; Iinuma, M; Lerner, UH; Modéer, T | 1 |
| Das, UN; Ramadevi, G; Rao, KP; Rao, MS | 1 |
| Costa, ME; Katz, KH; Ojeda, SR; Urbanski, HF | 1 |
| Fredholm, BB; Hänström, L; Lerner, U | 1 |
| Dziak, R; Rifkin, B; Vernillo, A | 1 |
| Wang, GX; Xie, H | 1 |
| Fujioka, H; Kishi, M; Masuda, Y; Miyazaki, H; Tan, T; Yokoyama, Y | 1 |
| Brunius, G; Modéer, T; Shinoda, K; Yucel-Lindberg, T | 1 |
| Andersson, G; Andurén, I; Bengtsson, A; Modéer, T | 1 |
14 other study(ies) available for phenytoin and dinoprostone
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Enhanced prostaglandin biosynthesis in human gingival fibroblasts isolated from patients treated with phenytoin.
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acids; Cells, Cultured; Child; Dinoprostone; Dose-Response Relationship, Drug; Epilepsy; Fibroblasts; Gingiva; Gingival Hyperplasia; Gingivitis; Humans; Interleukin-1; Phenytoin; Tumor Necrosis Factor-alpha; Up-Regulation | 1992 |
Phenytoin potentiates interleukin-1-induced prostaglandin biosynthesis in human gingival fibroblasts.
Topics: Arachidonic Acid; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; Fibroblasts; Gingiva; Humans; Interleukin-1; Phenytoin; Tritium; Tumor Necrosis Factor-alpha | 1992 |
Prostaglandins can modify gamma-radiation and chemical induced cytotoxicity and genetic damage in vitro and in vivo.
Topics: Alprostadil; Animals; Benzo(a)pyrene; Bone Marrow; Chromosome Aberrations; Dinoprost; Dinoprostone; DNA Damage; Female; Gamma Rays; Humans; Lymphocytes; Male; Mice; Micronucleus Tests; Phenytoin; Sister Chromatid Exchange; Sperm Head; Spermatozoa | 1989 |
Prostaglandin E2 releases luteinizing hormone-releasing hormone from the female juvenile hypothalamus through a Ca2+-dependent, calmodulin-independent mechanism.
Topics: Animals; Calcium; Calcium Channel Blockers; Calmodulin; Cyclic AMP; Dinoprostone; Estradiol; Female; Gonadotropin-Releasing Hormone; In Vitro Techniques; Kinetics; Median Eminence; Phenytoin; Prostaglandins E; Protein Kinase Inhibitors; Rats; Rats, Inbred Strains | 1988 |
Diphenylhydantoin inhibits parathyroid hormone and prostaglandin E2-stimulated bone resorption in mouse calvaria without affecting cyclic AMP formation.
Topics: Animals; Bone Resorption; Calcium; Cyclic AMP; Dinoprostone; Dose-Response Relationship, Drug; Glycoside Hydrolases; Mice; Parathyroid Hormone; Phenytoin; Prostaglandins E; Skull; Time Factors; Tritium; Verapamil | 1985 |
The effects of phenytoin on calcium uptake in osteoblastic cells.
Topics: Animals; Animals, Newborn; Biological Transport; Calcium; Cell Line; Cells, Cultured; Dinoprostone; Humans; Kinetics; Osteoblasts; Osteosarcoma; Parathyroid Hormone; Peptide Fragments; Phenytoin; Rats; Rats, Inbred Strains; Reference Values; Teriparatide | 1988 |
[Effects of combination of diphenylhydantoin and prostaglandin E2 on ouabain-induced arrhythmias].
Topics: Animals; Arrhythmias, Cardiac; Dinoprostone; Drug Synergism; Female; Guinea Pigs; Male; Myocardium; Norepinephrine; Ouabain; Phenytoin | 1988 |
Biopharmaceutical studies on hydantoin derivatives. V. Pharmacokinetics and pharmacodynamics of 5,5-diphenylhydantoin and 1-benzenesulfonyl-5,5-diphenylhydantoin.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Anticonvulsants; Brain; Dinoprostone; Injections, Intravenous; Injections, Intraventricular; Liver; Male; Mephenytoin; Mice; Phenytoin; Prostaglandins E; Protein Binding; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Effect of phenytoin on interleukin-1 beta production in human gingival fibroblasts challenged to tumor necrosis factor alpha in vitro.
Topics: Child; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Fibroblasts; Flurbiprofen; Gingiva; Gingival Hyperplasia; Humans; Indomethacin; Interleukin-1; Phenytoin; Tumor Necrosis Factor-alpha; Up-Regulation | 1996 |
Interleukin-1 beta and phenytoin reduce alpha 1 (I) procollagen mRNA expression in human gingival fibroblasts.
Topics: Anticonvulsants; Blotting, Northern; Cells, Cultured; Child; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Fibroblasts; Gene Expression Regulation; Gingiva; Humans; Indomethacin; Interleukin-1; Nucleic Acid Hybridization; Phenytoin; Procollagen; Prostaglandin-Endoperoxide Synthases; RNA, Messenger | 1996 |